Texas A&M University
Welcome,         Profile    Billing    Logout  
 44 Trials 
79 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kerr, David J
NCT04938388: Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care

Terminated
4
12
US
Semaglutide Pill, Semaglutide 3 mg, Semaglutide 7 mg, Semaglutide 14 mg, Fresh organic vegetables
Sansum Diabetes Research Institute, Novo Nordisk A/S
Diabetes Mellitus, Type 2, Glucose Metabolism Disorders (Including Diabetes Mellitus)
02/23
02/23
CHAT, NCT05293340: Continuous Glucose Monitoring and Hass Avocado Trial ("")

Terminated
N/A
50
US
Avocado Vouchers
Sansum Diabetes Research Institute, Hass Avocado Board
Dietary Habits, Diabetes Mellitus, Type 2
01/23
01/23
NCT05368454: Evaluation of a Digital Diabetes Self-Management Education and Support Program

Completed
N/A
100
US
Online Diabetes Self-Management Education and Support (DSMES) Program, Standard of Care
Omada Health, Inc., Abbott Diabetes Care, Evidation Health
Type 2 Diabetes
01/24
01/24
NCT05000840: Integrating Abbott Point-of-Care Technologies and the Community Scientist Model to Support HbA1c Testing Per ADA

Recruiting
N/A
750
US
Enrollment in existing SDRI diabetes education programs
Sansum Diabetes Research Institute, Abbott, DexCom, Inc.
Diabetes Mellitus, Type 2, Cardiovascular Diseases
07/24
12/24
NCT04991142: Models of Nutrition From Continuous Glucose Monitors

Completed
N/A
45
US
Texas A&M University, Sansum Diabetes Research Institute
Diabetes Mellitus, Type 2, Pre-diabetes, Diet Habit, Diet, Healthy
08/24
08/24
Riechman, Steven E
NCT06465888: Influence of Eggs on Cognitive Performance

Completed
N/A
106
US
egg whites, whole eggs, Omega-3 eggs, egg yolk
Texas A&M University, Egg Nutrition Center
Cognitive Function
03/20
03/20
NCT06489873: Lutein, Zeaxathin, and Fish Oil Supplementation

Recruiting
N/A
80
US
Active Comparator (Lutein, zeaxanthin, and fish oil supplement (LZF), Placebo Comparator
Texas A&M University, Allen Foundation Inc.
Cognitive Performance, Age-Related Macular Degeneration, Bone Loss
05/25
05/25
Deutz, Nicolaas
PREP DOD, NCT05346302: Persistent Readiness Through Early Prediction Immunization Study

Completed
1
249
US
Pneumovax 23, Typhim VI, Saline
Texas A&M University, Philips Healthcare, US Department of Defense - Defense Threat Reduction Agency
Inflammatory Response
12/22
12/22
NCT05400733: Prandial Metabolic Phenotype in Adults

Recruiting
N/A
50
US
Total Amino Acids, Essential Amino Acids, Essential Amino Acids + Hydroxy-methylbutyric acid (HMB), Essential Amino Acids + Leucine, Essential Amino Acids High, Placebo Water
Texas A&M University
Protein Metabolism
04/25
04/25
NCT05395390: COPD Circuit Exercise

Recruiting
N/A
200
US
Exercise (Resistance Training
Texas A&M University
OSA, Covid19, Residual Symptoms of COVID 19, COPD
05/23
05/24
Microdialysis, NCT06582381: Evaluation of Biomarkers for Predicting Macronutrient Intake

Recruiting
N/A
33
US
Meal set A, Meal set B, Meal set C, Meal set D
Texas A&M University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Glucose Metabolism, Amino Acid Metabolism
12/25
12/26
NCT06628349: Prandial Metabolic Phenotyping in Sarcopenic Older Adults Comparing Plant Based and Whey Based Protein

Recruiting
N/A
100
US
Whey Protein Isolate 90%, Soy Protein Isolate (90% Protein), Organic Pea Protein Isolate, Placebo (Water)
Texas A&M University
Protein Metabolism
01/26
01/26
Smith, Stephen
COMFORT, NCT05750589: Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections

Not yet recruiting
3
240
US
IRX-101, Providone-Iodine
iRenix Medical, Inc.
Retinal Disease
12/26
12/27
BRUIN-MCL-321, NCT04662255 / 2020-004553-72: Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)

Active, not recruiting
3
500
Europe, Canada, Japan, US, RoW
Pirtobrutinib, LOXO-305, LY3527727, Ibrutinib, Imbruvica, Acalabrutinib, Calquence, Zanubrutinib, Brukinsa
Loxo Oncology, Inc., Eli Lilly and Company
Lymphoma, Mantle-Cell
12/25
07/26
NCT04987294: Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease

Terminated
2a
19
US
ALLN-346, Engineered urate oxidase, Placebo, Matching placebo capsule
Allena Pharmaceuticals
Hyperuricemia, Gout, Chronic Kidney Diseases
09/22
09/22
NCT03401853: Pembrolizumab With Rituximab or Obinutuzumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell Lymphoma

Active, not recruiting
2
18
US
Laboratory Biomarker Analysis, Pembrolizumab, Keytruda, Lambrolizumab, MK-3475, SCH 900475, Rituximab, ABP 798, BI 695500, C2B8 Monoclonal Antibody, Chimeric Anti-CD20 Antibody, CT-P10, IDEC-102, IDEC-C2B8, IDEC-C2B8 Monoclonal Antibody, MabThera, Monoclonal Antibody IDEC-C2B8, PF-05280586, Rituxan, Rituximab Biosimilar ABP 798, Rituximab Biosimilar BI 695500, Rituximab Biosimilar CT-P10, Rituximab Biosimilar GB241, Rituximab Biosimilar IBI301, Rituximab Biosimilar PF-05280586, Rituximab Biosimilar RTXM83, Rituximab Biosimilar SAIT101, RTXM83, rituximab biosimilar TQB2303, rituximab-abbs, Truxima, Rituximab Biosimilar SIBP-02, Obinutuzumab, Anti-CD20 Monoclonal Antibody R7159, GA-101, GA101, Gazyva, huMAB(CD20), R7159, RO 5072759, RO-5072759, RO5072759
University of Washington, Merck Sharp & Dohme LLC
Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Follicular Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Follicular Lymphoma
12/23
12/25
RELIEF, NCT05747430: SteRilizing Eye SoLution to ImprovE Patient ComFort

Recruiting
2
75
US
IRX-101, Providone-Iodine
iRenix Medical, Inc.
Retinal Disease
06/24
08/24
NCT04626791: Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma

Recruiting
2
45
US
Acalabrutinib, ACP-196, Bruton Tyrosine Kinase Inhibitor ACP-196, Bortezomib, [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid, LDP 341, MLN341, PS-341, PS341, Velcade, Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, Cytarabine, .beta.-Cytosine arabinoside, 1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-.beta.-D-Arabinofuranosylcytosine, 1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-Beta-D-arabinofuranosylcytosine, 1.beta.-D-Arabinofuranosylcytosine, 2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-, 2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-, Alexan, Ara-C, ARA-cell, Arabine, Arabinofuranosylcytosine, Arabinosylcytosine, Aracytidine, Aracytin, Aracytine, Beta-Cytosine Arabinoside, CHX-3311, Cytarabinum, Cytarbel, Cytosar, Cytosine Arabinoside, Cytosine-.beta.-arabinoside, Cytosine-beta-arabinoside, Erpalfa, Starasid, Tarabine PFS, U 19920, U-19920, Udicil, WR-28453, Doxorubicin Hydrochloride, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI), ADM, Adriacin, Adriamycin, Adriamycin Hydrochloride, Adriamycin PFS, Adriamycin RDF, ADRIAMYCIN, HYDROCHLORIDE, Adriamycine, Adriblastina, Adriblastine, Adrimedac, Chloridrato de Doxorrubicina, DOX, DOXO-CELL, Doxolem, Doxorubicin HCl, Doxorubicin.HCl, Doxorubin, Farmiblastina, FI 106, FI-106, hydroxydaunorubicin, Rubex, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, Perrigo Prednisone, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisone Intensol, Prednisonum, Prednitone, Promifen, Rayos, Servisone, SK-Prednisone, Rituximab, ABP 798, BI 695500, C2B8 Monoclonal Antibody, Chimeric Anti-CD20 Antibody, CT-P10, IDEC-102, IDEC-C2B8, IDEC-C2B8 Monoclonal Antibody, MabThera, Monoclonal Antibody IDEC-C2B8, PF-05280586, Riabni, Rituxan, Rituximab ABBS, Rituximab ARRX, Rituximab Biosimilar ABP 798, Rituximab Biosimilar BI 695500, Rituximab Biosimilar CT-P10, Rituximab Biosimilar GB241, Rituximab Biosimilar IBI301, Rituximab Biosimilar JHL1101, Rituximab Biosimilar PF-05280586, Rituximab Biosimilar RTXM83, Rituximab Biosimilar SAIT101, Rituximab Biosimilar SIBP-02, rituximab biosimilar TQB2303, Rituximab PVVR, rituximab-abbs, Rituximab-arrx, Rituximab-pvvr, RTXM83, Ruxience, Truxima, Rituximab and Hyaluronidase Human, Rituxan Hycela, Rituximab Plus Hyaluronidase, Rituximab/Hyaluronidase, Rituximab/Hyaluronidase Human
Academic and Community Cancer Research United, National Cancer Institute (NCI)
Mantle Cell Lymphoma
08/24
08/28
NCT05453396: Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell Malignancies

Recruiting
2
40
US
Loncastuximab Tesirine, ADC ADCT-402, ADCT-402, Anti-CD19 PBD-conjugate ADCT-402, Loncastuximab Tesirine-lpyl, Zynlonta, MT 2111, MT-2111, MT2111
University of Washington
Post-Transplant Lymphoproliferative Disorder, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Neoplastic Post-Transplant Lymphoproliferative Disorder, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Follicular Lymphoma, Refractory Mantle Cell Lymphoma, Refractory Neoplastic Post-Transplant Lymphoproliferative Disorder
12/25
07/26
SIDNEY, NCT04669171 / 2020-003999-40: A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

Recruiting
1/2
60
Europe, US
EO2463, lenalidomide, Revlimid, rituximab, MabThera
Enterome
Follicular Lymphoma, Marginal Zone Lymphoma
05/26
05/32
NCT05455697: Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Large B-cell Lymphoma

Recruiting
1/2
35
US
Bone Marrow Biopsy, Cyclophosphamide, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphanum, Cyclostine, Cytophosphane, Cytoxan, Fosfaseron, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, Doxorubicin, 14-Hydroxydaunomycin, 23214-92-8, Adriablastin, Hydroxydaunomycin, Hydroxyl Daunorubicin, Hydroxyldaunorubicin, Prednisone, Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltra, Econosone, Lisacort, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, Predicor, Predicorten, Prednicort, Prednilonga, Prednisone Intensol, Prednisonum, Prednitone, Promifen, Rayos, Servisone, SK-Prednisone, Retifanlimab, 2226345-85-1, INCMGA 0012, INCMGA-0012, INCMGA00012, INCMGA0012, MGA 012, MGA-012, MGA012, Retifanlimab-dlwr, Zynyz, Rituximab and Hyaluronidase Human, Rituxan Hycela, Rituximab Plus Hyaluronidase, Rituximab/Hyaluronidase, Rituximab/Hyaluronidase Human, Tafasitamab, 1422527-84-1, Immunoglobulin, Anti-(Human Cd19 Antigen) (Human-mus musculus Monoclonal MOR00208 Heavy Chain), Disulfide with Human-mus musculus Monoclonal MOR00208 .Kappa.-chain,, Dimer, Monjuvi, MOR-00208, MOR00208, MOR208, Tafasitamab-cxix, XmAb5574, Vincristine, 22-Oxovincaleukoblastine, 57-22-7, LEUROCRISTINE, VCR, Vincrystine, Bone Marrow Aspiration, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide ventriculography, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Fludeoxyglucose F-18, 105851-17-0, 18FDG, Positron Emission Tomography, Medical Imaging, PET Scan, Positron Emission Tomography Scan, Computed Tomography, CAT Scan, Computed Axial Tomography, CT SCAN, Biospecimen Collection, Biological Sample Collection, Polatuzumab Vedotin, Antibody-Drug Conjugate DCDS4501A, Polivy
University of Washington
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma
01/26
07/26
KT333-TL-101, NCT05225584: Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients with Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

Active, not recruiting
1
120
US
KT-333
Kymera Therapeutics, Inc.
Non Hodgkin Lymphoma (NHL), Peripheral T-cell Lymphoma (PTCL), Cutaneous T-Cell Lymphoma (CTCL), Large Granular Lymphocytic Leukemia (LGL-L), T-cell Prolymphocytic Leukemia (T-PLL), Solid Tumors
02/25
03/25
STAR-V, NCT05024695: Evaluate the Safety and Effectiveness of iSTAR Medical's MINIjectâ„¢ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

Recruiting
N/A
975
Europe, Canada, US
MINIjectâ„¢ Implant
iSTAR Medical
Glaucoma
07/27
07/29
Castorino, Kristin
MKC-TI-193, NCT05904743: INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes

Completed
4
141
US
Afrezza, Technosphere Insulin, insulin degludec, Rapid-acting Insulin Analog, any FDA approved Rapid-acting Insulin Analog, Basal Insulin, any FDA approved Basal Insulin
Mannkind Corporation, Jaeb Center for Health Research
Diabetes Mellitus, Type 1
03/24
06/24
TRZ, NCT06009653: Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity

Terminated
4
32
US
Standard Care, Culturally-tailored dietary and behavioral intensive lifestyle intervention, Placebo, Tirzepatide
Washington University School of Medicine, Eli Lilly and Company, National Institute on Minority Health and Health Disparities (NIMHD)
Obesity, Metabolic Disease
05/24
05/24
QWINT-5, NCT05463744: A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

Completed
3
692
Europe, Japan, US, RoW
Insulin Efsitora Alfa, LY3209590 and Basal Insulin-FC, Insulin Degludec
Eli Lilly and Company
Type 1 Diabetes, Diabetes
05/24
05/24
INHALE-GDM, NCT06535789: Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes

Not yet recruiting
2/3
30
US
Inhaled Technosphere Insulin
Jaeb Center for Health Research, Mannkind Corporation
Diabetes, Gestational, Pregnancy Complications, Glucose Metabolism Disorders, Glucose Intolerance During Pregnancy
12/24
12/24
NCT04905628: Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus

Recruiting
N/A
100
US
Dexcom CGM System
DexCom, Inc.
Diabetes Mellitus
03/22
04/22
NCT05409131: Omnipod 5 System Compared to Pump Therapy

Active, not recruiting
N/A
200
Europe, US
Omnipod 5 System
Insulet Corporation
Type 1 Diabetes
09/23
01/25
SECURE-T2D, NCT05815342: OP5-005 Using Omnipod 5 in Adults With Type 2

Completed
N/A
343
US
Omnipod 5 Automated Glucose Control System
Insulet Corporation, Jaeb Center for Health Research
Type2 Diabetes
03/24
03/24
NCT05714059: Safety and Effectiveness of the MiniMedâ„¢ 780G System With DS5 CGM

Completed
N/A
250
US
Insulin Pump with Continuous Glucose Monitoring
Medtronic Diabetes
Type 1 Diabetes
12/23
12/23
NCT05238142: In-Home Study with MiniMedâ„¢ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults with Insulin-requiring Type 2 Diabetes

Active, not recruiting
N/A
575
US
MiniMedâ„¢ 780G Insulin Pump system
Medtronic Diabetes
Type 2 Diabetes Treated with Insulin
01/25
02/25
NCT06218147: Community-Based Nutrition-Lifestyle Therapy for Pregnant Latina Women With Diabetes

Recruiting
N/A
30
US
Nutrition-behavior lifestyle program, Plant forward dietary lifestyle intervention
Sansum Diabetes Research Institute
Diabetes Mellitus, Type 2, Diabetes Mel Gestational - in Pregnancy
12/24
12/25
NCT04991142: Models of Nutrition From Continuous Glucose Monitors

Completed
N/A
45
US
Texas A&M University, Sansum Diabetes Research Institute
Diabetes Mellitus, Type 2, Pre-diabetes, Diet Habit, Diet, Healthy
08/24
08/24
SBPlant, NCT05444595: Behavioral Plant-Based Dietary Intervention in Latinos

Not yet recruiting
N/A
40
US
Behavioral plant-based dietary intervention, Standard care
Washington University School of Medicine, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Sansum Diabetes Research Institute
Obesity, Metabolic Disease
02/25
05/25
NCT06719531: SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients with Type 1 and Type 2 Diabetes

Not yet recruiting
N/A
1500
US
Continuous Glucose Monitoring
Medtronic Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
12/25
12/25
Vincent, Kathleen L
NCT01886794: Hormonal Status on Blood Flow and Tissue in Pelvic Organ Prolapse

Terminated
4
10
US
Postmenopausal, topical vaginal estrogen cream, Estrace vaginal cream, Placebo Comparator: Postmenopausal, topical placebo cream, Placebo vaginal cream
The University of Texas Medical Branch, Galveston
Pelvic Floor Disorders
12/23
12/23
NCT04565925: Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries

Recruiting
2
24
US
Sildenafil Citrate, Revatio, Placebo, Lactose
The University of Texas Medical Branch, Galveston
Spinal Cord Injuries, Urinary Incontinence
12/25
12/25
NCT02983461: Use of Sildenafil for Treatment of Urinary Incontinence

Active, not recruiting
1
24
US
Sildenafil, Placebo
The University of Texas Medical Branch, Galveston
Urinary Incontinence
03/20
07/25
PrEP-Pod-IVR, NCT03255915: (TDF-FTC/Placebo IVR 28 Day Crossover Study)

Active, not recruiting
1
15
US
Tenofovir Disoproxil Fumarate (TDF)-Emtricitabine (FTC), Placebo
Oak Crest Institute of Science, The Miriam Hospital, Johns Hopkins University, University of California, Los Angeles, University of California, San Diego, Vanderbilt University, The University of Texas Medical Branch, Galveston, National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)
HIV Prevention
09/20
12/25
NCT06740253: Safety and Acceptability Study of a Placebo Antibody-Based Nonhormonal Contraceptive Intravaginal Ring

Not yet recruiting
N/A
20
US
Placebo intravaginal ring (IVR)
The University of Texas Medical Branch, Galveston, Mucommune, LLC., Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Healthy Female Subjects
12/25
07/26
Cowan, Rachel
VRWalk, NCT05005026: Virtual Walking Intervention for Neuropathic Pain in Spinal Cord Injury

Recruiting
N/A
250
US, RoW
VR Game 1, VR Game 2
Texas A&M University, United States Department of Defense, Richmond VA Medical Center, Immersive Experience Labs
Spinal Cord Injuries, Neuropathic Pain
09/25
09/26
NCT06661954: Comparison of Sacral Interface Pressure in Healthy Volunteers on Two Dynamic Pressure-Prevention Support Surfaces

Completed
N/A
18
US
Bed A - supine, Bed B - supine, Bed A - head of bed at 30 degrees, Bed B - head of bed at 30 degrees
University of Alabama at Birmingham
Healthy Volunteer, Pressure Distribution
10/24
10/24
Sheffield-Moore, Melinda
SPARC, NCT06800092: Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment

Recruiting
2/3
30
US
Sildenafil, Viagra
The University of Texas Medical Branch, Galveston
Cancer
06/30
06/30
NCT06050733: The Gut Microbiome and Immunotherapy Response in Solid Cancers

Recruiting
N/A
16
US
The University of Texas Medical Branch, Galveston
Cancer
12/25
12/25
NCT06098404: Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study

Recruiting
N/A
250
US
The University of Texas Medical Branch, Galveston
Cancer
10/25
10/25
Engelen, Marielle P
PREP DOD, NCT05346302: Persistent Readiness Through Early Prediction Immunization Study

Completed
1
249
US
Pneumovax 23, Typhim VI, Saline
Texas A&M University, Philips Healthcare, US Department of Defense - Defense Threat Reduction Agency
Inflammatory Response
12/22
12/22
NCT06801964: AECOPD and Nutritional Supplementation in COPD

Completed
N/A
5
US
Stable isotope infusion, Protein and Fish Oil, Protein and Olive Oil, Carbohydrate and Olive Oil
Texas A&M University
Obstructive Pulmonary Disease, Exacerbation Copd
01/19
01/19
NCT04461236: Isoleucine Intake and Intermediary Metabolism in Type 2 Diabetes

Recruiting
N/A
90
US
Oral Supplement, Placebo
Texas A&M University
Type 2 Diabetes
05/22
05/23
NCT04459156: Fiber Metabolism in Chronic Obstructive Pulmonary Disease

Recruiting
N/A
150
US
Fiber Inulin, Placebo Maltodextrin
Texas A&M University
Chronic Obstructive Pulmonary Disease, Aging
12/22
12/23
NCT05400733: Prandial Metabolic Phenotype in Adults

Recruiting
N/A
50
US
Total Amino Acids, Essential Amino Acids, Essential Amino Acids + Hydroxy-methylbutyric acid (HMB), Essential Amino Acids + Leucine, Essential Amino Acids High, Placebo Water
Texas A&M University
Protein Metabolism
04/25
04/25
NCT05395390: COPD Circuit Exercise

Recruiting
N/A
200
US
Exercise (Resistance Training
Texas A&M University
OSA, Covid19, Residual Symptoms of COVID 19, COPD
05/23
05/24
NCT06628349: Prandial Metabolic Phenotyping in Sarcopenic Older Adults Comparing Plant Based and Whey Based Protein

Recruiting
N/A
100
US
Whey Protein Isolate 90%, Soy Protein Isolate (90% Protein), Organic Pea Protein Isolate, Placebo (Water)
Texas A&M University
Protein Metabolism
01/26
01/26
NCT06693544: Peanut Sip Feeding Protocol

Enrolling by invitation
N/A
15
US
Peanut protein
Texas A&M University
Protein Metabolism
10/25
10/25
Sellers, Stacey
COPE+OT, NCT04523922: Oxytocin to Enhance Integrated Treatment for AUD and PTSD

Recruiting
2
180
US
40 IU Intranasal Oxytocin, oxytocin, Placebo, saline, Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure, COPE
Medical University of South Carolina, National Institute on Alcohol Abuse and Alcoholism (NIAAA)
PTSD, Alcohol Use Disorder
01/26
01/26
CPT+RP, NCT05959434: Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and PTSD

Recruiting
2
200
US
Cognitive Processing Therapy + Relapse Prevention, Relapse Prevention
Texas A&M University, Medical University of South Carolina, National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Posttraumatic Stress Disorder, Alcohol Use Disorder
06/27
07/28
START, NCT05374798: Wearable Technology and Alcohol-Facilitated Intimate Partner Violence

Active, not recruiting
N/A
92
US
Heart Rate Variability-Biofeedback (HRV-B) via Smartwatch Device Intervention
Medical University of South Carolina, National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Alcohol Abuse, IPV, Couples
05/24
11/24
NCT05786157: Advancing Couple and Family Alcohol Treatment Through Patient-Oriented Research and Mentorship

Recruiting
N/A
140
US
Alcohol Administration
Medical University of South Carolina
Alcohol Use Disorder, Posttraumatic Stress Disorder, Couples
10/28
10/29
Randolph, Kate
SPARC, NCT06800092: Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment

Recruiting
2/3
30
US
Sildenafil, Viagra
The University of Texas Medical Branch, Galveston
Cancer
06/30
06/30
NCT06050733: The Gut Microbiome and Immunotherapy Response in Solid Cancers

Recruiting
N/A
16
US
The University of Texas Medical Branch, Galveston
Cancer
12/25
12/25
NCT06098404: Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study

Recruiting
N/A
250
US
The University of Texas Medical Branch, Galveston
Cancer
10/25
10/25
Vincent, Kathy
NCT04565925: Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries

Recruiting
2
24
US
Sildenafil Citrate, Revatio, Placebo, Lactose
The University of Texas Medical Branch, Galveston
Spinal Cord Injuries, Urinary Incontinence
12/25
12/25
Vujanovic, Anka
CPT+RP, NCT05959434: Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and PTSD

Recruiting
2
200
US
Cognitive Processing Therapy + Relapse Prevention, Relapse Prevention
Texas A&M University, Medical University of South Carolina, National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Posttraumatic Stress Disorder, Alcohol Use Disorder
06/27
07/28
NCT04836442: PFI Hazardous Drinkers With Subclinical PTSD

Not yet recruiting
N/A
100
US
Alcohol-PTSD-PFI (AP-PFI), Active Comparison Condition (C-PFI)
University of Houston
Hazardous Drinking, Posttraumatic Stress Disorder
12/22
07/23
HAZMAT, NCT04909216: Mindful Attention Training Workshop for Firefighters

Completed
N/A
82
US
Mindful Attention Workshop
University of Houston
Post Traumatic Stress Disorder, Mindfulness, Firefighters, Trauma, Mental Disorders
04/23
04/23
Glantz, Namino
NCT04991142: Models of Nutrition From Continuous Glucose Monitors

Completed
N/A
45
US
Texas A&M University, Sansum Diabetes Research Institute
Diabetes Mellitus, Type 2, Pre-diabetes, Diet Habit, Diet, Healthy
08/24
08/24
Mortazavi, Bobak J
NCT06065319: Wearables and Cardiac Rehabilitation

Active, not recruiting
N/A
18
US
Wearable Sensors
Texas A&M University, Ascension Health
Cardiac Rehabilitation
06/24
10/24
NCT04991142: Models of Nutrition From Continuous Glucose Monitors

Completed
N/A
45
US
Texas A&M University, Sansum Diabetes Research Institute
Diabetes Mellitus, Type 2, Pre-diabetes, Diet Habit, Diet, Healthy
08/24
08/24
Gutierrez-Osuna, Ricardo
NCT04991142: Models of Nutrition From Continuous Glucose Monitors

Completed
N/A
45
US
Texas A&M University, Sansum Diabetes Research Institute
Diabetes Mellitus, Type 2, Pre-diabetes, Diet Habit, Diet, Healthy
08/24
08/24
Smallman, Rachel E
NCT05208593: Alcohol PBS and Thinking About the Past

Completed
N/A
413
US
Negative Event + Counterfactual Task, Personalized Normative Feedback, Negative Event + Factual Thinking Task, Negative Event Only
Texas A&M University, University of Central Florida
Alcohol Drinking in College
11/22
12/22
NCT05192226: Counterfactual Strategies, Physical Activity, and Wearable Trackers

Completed
N/A
40
US
Counterfactual Strategy, Counterfactual thinking, The functional theory of counterfactual thinking
Texas A&M University, U.S. National Science Foundation
Financial Stress, Socioeconomic Status, Social Status
12/22
12/22
Fields, Sherecce A
NCT05208593: Alcohol PBS and Thinking About the Past

Completed
N/A
413
US
Negative Event + Counterfactual Task, Personalized Normative Feedback, Negative Event + Factual Thinking Task, Negative Event Only
Texas A&M University, University of Central Florida
Alcohol Drinking in College
11/22
12/22
NCT05725408: Comparison of a Telehealth Versus In-person Intervention for Binge Eating

Completed
N/A
38
US
Dialectical behavior therapy-informed group eating intervention protocol (telehealth), Dialectical behavior therapy-informed group eating intervention protocol (in-person)
Texas A&M University, Psi Chi, American Psychological Foundation, Academy for Eating Disorders
Binge Eating
08/23
08/23
Dvorak, Rob
NCT05208593: Alcohol PBS and Thinking About the Past

Completed
N/A
413
US
Negative Event + Counterfactual Task, Personalized Normative Feedback, Negative Event + Factual Thinking Task, Negative Event Only
Texas A&M University, University of Central Florida
Alcohol Drinking in College
11/22
12/22
Higgins, Amanda
WISE, NCT05390775: Written Exposure Therapy to Improve Lives After Stress Exposure

Completed
N/A
41
US
Written Exposure Therapy (WISE), Non-emotional Writing
University of North Carolina, Chapel Hill, University of Florida Health, Indiana University, University of Massachusetts, Worcester, Washington University School of Medicine, Henry Ford Health System, US Department of Veterans Affairs
Post Traumatic Stress Disorder
10/23
10/23
NCT06330181: Virtual Walking Therapy for Neuropathic Pain Following Incomplete Spinal Cord Injury

Recruiting
N/A
48
US
VR Game 1, VR Game 2
Texas A&M University, United States Department of Defense, Immersive Experience Labs
Spinal Cord Injuries, Neuropathic Pain
01/26
01/27
McCord, Carly
NCT05725408: Comparison of a Telehealth Versus In-person Intervention for Binge Eating

Completed
N/A
38
US
Dialectical behavior therapy-informed group eating intervention protocol (telehealth), Dialectical behavior therapy-informed group eating intervention protocol (in-person)
Texas A&M University, Psi Chi, American Psychological Foundation, Academy for Eating Disorders
Binge Eating
08/23
08/23
Douglas, Robyn
NCT05725408: Comparison of a Telehealth Versus In-person Intervention for Binge Eating

Completed
N/A
38
US
Dialectical behavior therapy-informed group eating intervention protocol (telehealth), Dialectical behavior therapy-informed group eating intervention protocol (in-person)
Texas A&M University, Psi Chi, American Psychological Foundation, Academy for Eating Disorders
Binge Eating
08/23
08/23
Jafari, Roozbeh
NCT06065319: Wearables and Cardiac Rehabilitation

Active, not recruiting
N/A
18
US
Wearable Sensors
Texas A&M University, Ascension Health
Cardiac Rehabilitation
06/24
10/24

Download Options